On Tuesday, Cellebrite DI Ltd (NASDAQ: CLBT) opened higher 1.32% from the last session, before settling in for the closing price of $18.24. Price fluctuations for CLBT have ranged from $6.51 to $18.75 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Technology Sector giant was 18.79%. Company’s average yearly earnings per share was noted 51.35% at the time writing. With a float of $61.62 million, this company’s outstanding shares have now reached $203.23 million.
Let’s determine the extent of company efficiency that accounts for 1008 employees. In terms of profitability, gross margin is 84.19%, operating margin of 13.85%, and the pretax margin is -26.72%.
Cellebrite DI Ltd (CLBT) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Software – Infrastructure industry is another important factor to consider. The insider ownership of Cellebrite DI Ltd is 70.39%, while institutional ownership is 33.52%. The most recent insider transaction that took place on Oct 15 ’24, was worth 2,853,245. Before that another transaction happened on Sep 16 ’24, when Company’s Officer proposed sale 100,000 for $17.51, making the entire transaction worth $1,751,000.
Cellebrite DI Ltd (CLBT) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted 0.1 earnings per share (EPS) for the quarter, besting the agreed prediction (set at 0.05) by 0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 51.35% per share during the next fiscal year.
Cellebrite DI Ltd (NASDAQ: CLBT) Trading Performance Indicators
Check out the current performance indicators for Cellebrite DI Ltd (CLBT). In the past quarter, the stock posted a quick ratio of 1.69. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.61. Likewise, its price to free cash flow for the trailing twelve months is 42.42.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.53, a number that is poised to hit 0.07 in the next quarter and is forecasted to reach 0.30 in one year’s time.
Technical Analysis of Cellebrite DI Ltd (CLBT)
Looking closely at Cellebrite DI Ltd (NASDAQ: CLBT), its last 5-days average volume was 0.88 million, which is a drop from its year-to-date volume of 1.13 million. As of the previous 9 days, the stock’s Stochastic %D was 60.77%. Additionally, its Average True Range was 0.51.
During the past 100 days, Cellebrite DI Ltd’s (CLBT) raw stochastic average was set at 96.70%, which indicates a significant increase from 75.11% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 19.18% in the past 14 days, which was lower than the 38.77% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $17.34, while its 200-day Moving Average is $12.88. However, in the short run, Cellebrite DI Ltd’s stock first resistance to watch stands at $18.66. Second resistance stands at $18.85. The third major resistance level sits at $19.20. If the price goes on to break the first support level at $18.13, it is likely to go to the next support level at $17.78. Now, if the price goes above the second support level, the third support stands at $17.60.
Cellebrite DI Ltd (NASDAQ: CLBT) Key Stats
There are currently 205,932K shares outstanding in the company with a market cap of 3.85 billion. Presently, the company’s annual sales total 325,110 K according to its annual income of -81,100 K. Last quarter, the company’s sales amounted to 95,710 K and its income totaled -23,810 K.
